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Background: Allergic sensitisation to food may occur through non-gastrointestinal routes such as via skin or lung.
We recently demonstrated in mice that cutaneous or respiratory pre-exposures to peanut proteins on intact epithelia
induce a Th2 priming and allow subsequent oral sensitization without the use of adjuvant. We then aimed to assess
the impact of a similar pattern of exposure to another relevant food allergen, cows’ milk.
Findings: The humoral and cellular immune response induced in BALB/cJ mice after repeated cutaneous applications
on intact skin or after intranasal administration of cows’ milk proteins was analysed. In order to assess the potential
effect of the food matrix, we used either a purified major cows’ milk allergen, β-lactoglobulin (BLG), or whole cows’ milk
containing the same amount of BLG. We then studied the impact of these pre-exposures on a subsequent oral
exposure to milk in the presence or absence of the mucosal Th2 adjuvant, Cholera toxin (CT). Cutaneous
applications of milk induced production of BLG-specific IgE and IgG1 in 5 and 8 mice out of 20 respectively,
whereas purified BLG alone did not. Intranasal exposure to milk, but not to BLG, led to BLG-specific IgG1
production in 8 out of 20 mice. Notably, cutaneous pre-exposure to milk favours further oral sensitisation
without CT, while intra-nasal pre-exposure to BLG prevents further experimental sensitisation.
Conclusions: Altogether, our results thus demonstrated that the immune response induced after non-gastrointestinal
exposure to food depends on the allergen, the matrix and the route of exposure.
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Introduction
Type I hypersensitivity immune responses represent about
60% of cases of cows’ milk allergy, the most common food
allergy in early life. It involves the production of IgE
antibodies specific to cows’ milk proteins such as β-
lactoglobulin (BLG) or caseins, the major cows’ milk
allergens [1,2]. Recent studies suggest that high con-
sumption of peanut in the household during infancy
is a risk factor for peanut allergy. Lack and collabora-
tors suggested that cutaneous exposure to low-doses
of a food would induce sensitisation while early con-
sumption of food would rather induce oral tolerance
[3]. It is possible for humans to be exposed to milk* Correspondence: karine.adel-patient@cea.fr
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unless otherwise stated.proteins via the skin as it enters into the composition
of many products applied to the skin. As an example, ana-
phylaxis in a 12-month-old boy has been described after
skin application of an ointment containing milk protein
such as caseins [4]. A study also demonstrates the pres-
ence of BLG in house dust suggesting that BLG could be
available for skin contact and/or inhalation [5].
Most animal models studying epicutaneous adminis-
tration demonstrated that disruption and inflammation
of the skin by tape stripping is necessary to induce effi-
cient sensitisation [6-9]. One study also described effi-
cient cutaneous sensitisation to milk proteins without
skin abrasion [10]. However, in our opinion, this model
didn’t reflect realistic environmental exposure as the
protein applications were performed using high doses of
proteins and a patch applied for 24 hours, which may in-
crease the skin permeability and therefore favour pene-
tration of allergens. It has also been shown that allergicThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Experimental schedule [12]. (A) In a first set of experiments, mice were exposed to proteins on intact skin. Mice were anaesthetized
and their abdomens were carefully shaved with an electric clipper. The remaining hairs were removed using a depilatory cream (Veet®) and
the skin was then gently cleaned with water. Skin treatments were performed 4 to 6 days after depilation to be sure that no more lesions or
inflammation are present [12]. Once a week for 6 weeks, 100 μg of purified BLG diluted in 30 μl of DPBS or 30 μl of milk containing the equivalent
amount of BLG was then spread on the depilated skin of anaesthetized mice (n = 19-20/group). After 40 minutes, skin was gently cleaned with water.
Control mice received 30 μl of PBS (n = 19/group). According to the same schedule, other groups of mice were exposed via the respiratory tract by
intranasal administration of 50 μg of purified BLG diluted in 10 μl of DPBS or 10 μl of milk containing the equivalent amount of BLG (n = 20/group).
Control mice received 10 μl of PBS. In both the experimental groups, after last administration, 6 mice per group were sacrificed. Spleen and ILN were
removed and cells isolated. Systemic specific cytokine secretion was then assessed after ex vivo restimulation with 20 μg of BLG. (B) After the six
cutaneous or intra-nasal exposures, the remaining mice from each of the experimental groups were separated into 2 subgroups (n = 7-8/subgroup).
One group was experimentally sensitized by gavage with 6 mg of milk proteins mixed with Cholera toxin (10 μg/administration) [18]. The other mice
received 6 mg of milk proteins in the absence of CT. Control mice consisted of mice pre-exposed with PBS then gavaged with milk +/− CT. Some mice







































Figure 2 Immune response induced after cutaneous applications of BLG or whole milk. Mice received 30 μl of PBS, purified BLG or milk
(n = 19-20/group) on intact skin. Serum samples were collected after 6 cutaneous applications and BLG-specific IgE (A) and IgG1 (B) antibodies
were quantified on individual serum samples. The numbers of positive mice are indicated above each group. Results are reported in ng/ml derived
from standard curves obtained with calibrated anti-BLG purified monoclonal IgG1 or IgE antibodies [15]. Non-specific binding (NSB) was determined
using sera from naive mice. A response was considered significant when higher than NSB + 3σ. (C) Systemic specific IL-4, IL-5 and IL-13 secretions were
assessed after ex vivo restimulation of splenocytes with BLG.
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Figure 3 Immune response induced after intra-nasal
administrations of BLG or whole milk. Mice received 10 μl
of PBS, purified BLG or milk intranasally (n = 20/group). (A)
Serum samples were collected after 6 intra-nasal administrations and
BLG-specific IgG1 were quantified on individual serum samples. The
numbers of positive mice are indicated above each group. A response
was considered significant when higher than NSB + 3σ. (B) Systemic
specific IL-13, IL-5 and IL-4 secretion was assessed after ex vivo
restimulation of splenocytes with BLG.
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nasal exposure in mice but needs the use of adjuvant
[11]. However, to our knowledge, the effect of short time
exposures to cow’s milk through an intact skin or intra-
nasally, at the same time as the impact of such adminis-
tration on further oral exposure has not been extensively
investigated. We recently demonstrated in mice that cu-
taneous or respiratory exposures to peanut proteins
through intact epithelia induce a Th2 priming. Moreover,
this pre-exposure favours subsequent oral sensitization
without the need of Th2 mucosal adjuvant [12]. We thus
aimed to extend our observations to cows’ milk, a major
allergenic food in infants by assessing the immune im-
pact of repeated short-term cutaneous applications on
intact skin or of repeated respiratory administrations of
allergens from cow’s milk in BALB/c mice.
Materials and methods
Commercial unheated microfiltrated cows’ milk (Lait
Marguerite, Villefranche-sur-saône, France) was used as
whole milk (thereafter called “milk”). BLG was purified
from the same source of milk using selective precipitation
and chromatography and characterized as previously de-
scribed [1,13]. BLG concentration in cows’ milk was con-
firmed using specific BLG immunoassay, ensuring that
mice receiving pure BLG or milk received the same quan-
tity of BLG [14].
Female BALB/cJ mice, 5 week-old, were purchased
from CERJ (Centre d’Elevage René Janvier, Le Genest-
Saint-Isle, France), and were housed in filtered cages
under normal Specified Pathogen Free husbandry condi-
tions (autoclaved bedding and sterile water). Mice were
acclimated for 2 weeks before experimentation. They
received a diet in which BLG was not detected using spe-
cific immunoassays developed in the laboratory [14].
All animal experiments were performed according to
European Community rules of animal care and with
authorization N° 91–368 of the French Veterinary Services.
In a first set of experiments, we compared the effect of
cutaneous or respiratory exposure to purified BLG or
cows’ milk on the immune response to BLG as previ-
ously described (Figure 1A) [12]. Mice were then further
either orally exposed to cow’s milk or experimentally
sensitized to cows’ milk via the oral route using Cholera
toxin (CT) as an adjuvant (Figure 1B). The humoral re-
sponse was assessed by quantitative measurements of
BLG-specific IgE and IgG1 antibodies on individual
serum samples collected at the end of the two stages of
the protocol as described elsewhere [15,16]. The cellular
response was assayed after restimulations of immune
cells from spleen collected at the end of the two stages
of the protocol. Organs were pooled within groups to assess
cytokine production under specific ex vivo re-stimulation,
as described previously [17]. Specific secretion wascalculated by subtraction of non-specific secretion in-
duced by ovalbumin. No statistical analysis was performed
as results were obtained from pooled organs.
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test was performed, using the Kruskal-Wallis test followed
by Dunn’s multiple comparisons test (DMCT). Statistical
analyses were performed using GraphPad Prism 5.01 soft-
ware (GraphPad software, San Diego, CA, USA).
Results
After 6 cutaneous applications, milk triggered significant
BLG-specific IgE and IgG1 responses in 5 and 8 out of
20 mice, respectively (Figure 2A and B). Conversely, only
1 and 2 mice out of 19 showed BLG-specific IgE and
IgG1, respectively, in the group that received the puri-
fied BLG. Systemic BLG-specific Th2 cytokine secretion
was also detected in both groups of mice exposed toFigure 4 Impact of cutaneous pre-exposition on further oral exposure
BLG or milk received 6 mg of milk proteins in the presence (○) or absence
Serum samples were collected at day 83 and BLG-specific IgE (A) and IgG1 (B
**p < 0.01, ***p < 0.001 using Kruskal-Wallis and Dunn’s multiple compa
IgE/IgG1 ratio between PBS or milk pre-exposed mice at the end of thBLG or milk (Figure 2C). We also detected low systemic
IFN-γ secretion in cells from BLG or milk treated mice
(data not shown).
In contrast, no specific IgE could be detected after 6
intra-nasal exposures (not shown) whereas intra-nasal
administrations of milk but not of BLG induced BLG-
specific IgG1 response in 7 out of 20 mice (Figure 3A).
Systemic secretion of IL-13, IL-4 and IL-5 was evidenced
in cells from milk-treated mice but not from control or
BLG-treated mice (Figure 3B). No BLG-specific IFNγ se-
cretion was detected, irrespective of the group treated.
We further assessed the effect of cutaneous exposure to
BLG or to milk on subsequent oral exposure to milk in
the presence or absence of the Th2 mucosal adjuvant CT.to milk +/− CT. Mice pre-exposed via the cutaneous route to PBS,
(●) of CT (n = 7-8/group) according to the protocol depicted in Figure 1.
) antibodies were quantified on individual serum samples. *p < 0.05,
rison post test when compared to naive group. (C) BLG-specific
e protocol.
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exposed to PBS by cutaneous route and then experimen-
tally sensitized by oral exposure to milk in the presence of
CT, were efficiently sensitized to BLG as they displayed
significant BLG-specific IgE and IgG1 (Figure 4A and B)
and high BLG-specific Th2 cytokine secretion (Figure 5)
when compared to naive mice. Milk or BLG cutaneous
pre-exposition also led to significant sensitisation after the
oral administration of milk in the presence of CT, but no
difference was evidenced when compared to PBS pre-
exposed mice. In the absence of CT, PBS and BLG pre-
exposed mice did not produce significant specific IgE or
IgG1 at the end of the protocol (Figure 4A and B). No
specific Th2 cytokine secretion was detected in corre-
sponding PBS-treated mice, whereas BLG pre-exposure
led to significant cytokine production (Figure 5). This sug-
gests the induction of BLG-specific Th2 cells in those
latter mice, although no specific IgE could be evidenced.
Conversely and as expected from the results shown in
Figure 2A, mice cutaneously pre-exposed to milk pro-
duced significant BLG-specific IgE (Figure 4A), IgG1
(Figure 4B) and Th2 cytokines (Figure 5) after 6 gavages
with milk without CT. Interestingly, the IgE/IgG1 ratio
was higher in milk pre-exposed mice when compared to
mice pre-exposed to PBS and then experimentally sensi-
tized irrespective of the use of CT (Figure 4C).
In parallel, we assessed the impact of intranasal pre-
exposure on subsequent oral exposure to milk in the pres-
ence or absence of Th2 mucosal adjuvant. As expected,
PBS pre-exposed mice displayed a significant BLG-specific
IgE production after gavages with milk and CT whereas
no significant response was evidenced in the absence
of CT (Figure 6). Mice that received oral administrations

























Figure 5 Cytokine secretion by reactivated splenocytes. At the end of
and further gavaged with milk in the presence (□) or in the absence (■) of
after ex vivo restimulation of splenocytes with 20 μg of BLG. IL-4, IL-13 and
(Biorad) following manufacturer’s instructions. Specific secretion was calcula
No statistical analysis was performed as results were obtained from pooledBLG-specific IgE whatever the pre-exposure (Figure 6).
Interestingly, mice that were intra-nasally pre-exposed
to BLG did not produce significant BLG-specific IgE
(Figure 6) after oral gavages with milk in the presence of
CT compared to naïve mice. Moreover, the production of
IgE in BLG pre-exposed mice was significantly lower from
PBS pre-exposed mice. The absence of Th2 cell activation
in these mice was confirmed by analysis of cytokine secre-
tion (not shown). Mice pre-exposed to milk then experi-
mentally sensitized demonstrated an intermediate profile:
The levels of BLG-specific IgE were slightly lower in milk
pre-exposed mice than that observed in PBS pre-exposed
mice but the difference was not statistically significant.
The same results were observed with BLG-specific IgG1
(not shown).
Discussion
In the present work, we exposed mice to milk or a purified
milk allergen through intact skin [12], by mean of applica-
tions not exceeding 40 minutes and without any patch. As
respiratory exposure to food proteins can also induce Th2
responses [11,19], we also assessed the effect of intra-nasal
administration of milk allergens.
We first demonstrated that cutaneous exposure to
milk induced the production of BLG-specific IgE and
IgG1 while purified BLG did not. Milk exposure by the
intranasal route was also more immunogenic than puri-
fied BLG exposure. In milk-treated mice via the cutane-
ous or i.n. route, response was mainly directed against
BLG. In both groups, no specific response against lacto-
ferrin was evidenced and only 3 mice out of 20 produced
IgG1, but not IgE, against whole caseins (not shown).
Systemic casein-specific secretion of IL-5 and IL-13 was
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S BLG milk
IL-13 IL-5
the protocol, mice from groups pre-exposed by the cutaneous route
CT were sacrificed. Systemic specific cytokine secretion was assessed
IL-5 were assayed using mouse cytokine kit and BioPlex apparatus
ted by subtraction of non-specific secretion induced by ovalbumin.
organs.
Figure 6 Impact of intra-nasal pre-exposition on further oral exposure to milk +/− CT. Respiratory pre-exposed mice (PBS, BLG, milk)
received 6 mg of milk proteins in the presence (○) or absence (●) of CT (n = 7-8/group) according to the protocol depicted in Figure 1.
Serum samples were collected at day 83 and BLG-specific IgE antibodies were quantified on individual serum samples. *p < 0.05, **p < 0.01,
***p < 0.001 using Kruskal-Wallis and Dunn’s multiple comparison posttest when compared to naive group. a indicates p < 0.05 using Kruskal-Wallis
comparison between specified group.
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on BLG presentation to the immune system and/or on
its activation. Milk contains several immunomodulatory
proteins [20] and fat that could act as an adjuvant. In-
deed, a specific lipid fraction of Brazil nuts has been
demonstrated to be involved in the immunogenicity of
Ber e 1, a brazil nut major allergen [21].
We previously observed that cutaneous or intranasal
exposure to purified Ara h 1 induced a strong Ara h 1-
specific IgG1 although no IgE could be detected. It is
interesting to note that Ara h 1, a large protein (62 KDa)
was more immunogenic that a smaller one, i.e. BLG (18
KDa), especially through the skin or pulmonary epithe-
lia. This was also demonstrated after intra-peritoneal
administrations of the corresponding purified proteins,
then further suggesting different intrinsic allergenic prop-
erties of these major allergens [22].
When we further gavaged cutaneously pre-exposed mice
without CT, only milk pre-exposed mice produced specific
IgE, demonstrating that cutaneous pre-exposure to milk
favours further oral sensitisation without the need for a
Th2 adjuvant. Although we did not assess the clinical
allergy outcome, for instance through an oral challenge
with milk or purified BLG, the model presented here,
using a first Th2 priming stage of environmental-like ex-
posure then a second stage of oral exposure, could be used
as a relevant model of food allergy sensitisation without
adjuvant.
Conversely, intra-nasal pre-exposure to milk did not
allow subsequent oral sensitisation without the use of
the Th2 adjuvant. Intra-nasal pre-exposure to BLG even
seems to prevent further sensitization experimentally in-
duced by oral gavages with milk in the presence of CT,
as corresponding mice did not produced specific IgE nor
Th2 cytokines after reactivation of spleen cells (Figure 2).
Intra-nasal pretreatment with BLG did not lead tosignificant Th2 nor Th1 response, both at the cellular
and humoral levels, suggesting the absence of induction
of effector specific and/or the induction of immune tol-
erance. A high dose of BLG administered via the gastro-
intestinal tract also induces efficient tolerance with
induction of Tregs [17]. Indeed, Tregs can be promoted
via an allergen exposure through respiratory route [23]
and in steady state conditions DCs seems to induce
Tregs rather than T effectors cells [24]. Further studies
aiming at analyzing Treg induction in lymph nodes after
intranasal BLG administration could then be interesting,
but we can already hypothesize that the oral route is not
the only one to promote specific tolerance. However, the
balance between tolerance and sensitisation appears to
be allergen-dependent as we previously demonstrated
that respiratory pre-exposure to purified Ara h 1 rather
favours subsequent oral sensitisation.
In summary, these results further suggest that non
gastrointestinal exposure to food proteins, i.e. via the cu-
taneous or respiratory route, may lead to Th2 priming
facilitating a subsequent sensitization via the oral route.
However, this priming to food proteins is dependent on
the allergen considered, the route of exposure and the
matrix containing the allergen. Moreover, we showed
that cutaneous exposure to milk on intact skin favours
subsequent oral sensitisation without the use of CT, pro-
viding an interesting adjuvant-free experimental model
of cows’ milk food allergy combining environmental and
oral exposure.Abbreviations
BLG: Bovine β-lactoglobulin; CT: Cholera toxin.
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